Fat Embolism Syndrome in Duchenne Muscular Dystrophy Patients: Early Recognition and Aggressive Therapy

Area of Science:

• Neurology
• Pediatrics
• Critical Care Medicine

Background:

• Duchenne muscular dystrophy (DMD) is a progressive genetic disorder affecting muscle strength.
• Acute neurological deterioration and respiratory failure are severe complications in DMD.
• Fat Embolism Syndrome (FES) is a rare but serious condition typically associated with fractures or orthopedic procedures.

Observation:

• Two pediatric patients with Duchenne muscular dystrophy presented with sudden severe neurological decline and respiratory failure.
• Both patients required mechanical ventilation due to hypoxic respiratory failure.
• Clinical presentation in both cases met the diagnostic criteria for Fat Embolism Syndrome.

Findings:

• Early identification of Fat Embolism Syndrome is crucial in pediatric Duchenne muscular dystrophy patients with neurological and respiratory symptoms.
• Aggressive supportive management, including mechanical ventilation and hemodynamic support (right ventricular afterload reduction, blood transfusion), facilitated patient survival.
• Successful treatment resulted in complete recovery without residual neurological or physical deficits.

Implications:

• Fat Embolism Syndrome should be strongly considered in the differential diagnosis of acute neurological and respiratory compromise in Duchenne muscular dystrophy patients.
• This case series highlights the importance of prompt and intensive multidisciplinary critical care for managing FES in this vulnerable population.
• The findings suggest that early and aggressive supportive therapy can significantly improve outcomes for Duchenne muscular dystrophy patients experiencing FES.